Detalles de la búsqueda
1.
Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk.
Int J Cancer
; 144(11): 2746-2761, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30426475
2.
Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy.
Ann Surg Oncol
; 26(3): 869-875, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30607764
3.
[Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test]. / Screening per il tumore polmonare in soggetti ad alto rischio: diagnosi precoce con TC spirale associata a stratificazione del rischio con miRNA circolanti.
Epidemiol Prev
; 40(1 Suppl 1): 42-50, 2016.
Artículo
en Italiano
| MEDLINE | ID: mdl-26951732
4.
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.
Proc Natl Acad Sci U S A
; 108(9): 3713-8, 2011 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21300873
5.
Assessment of circulating microRNAs in plasma of lung cancer patients.
Molecules
; 19(3): 3038-54, 2014 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24619302
6.
Detection of (pre)cancerous colorectal lesions in Lynch syndrome patients by microsatellite instability liquid biopsy.
Cancer Gene Ther
; 2024 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38332046
7.
A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer.
Front Oncol
; 12: 911613, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35928879
8.
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening.
Cancer Epidemiol Biomarkers Prev
; 31(11): 2020-2029, 2022 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36112827
9.
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway.
Pharmaceuticals (Basel)
; 15(3)2022 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35337095
10.
Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial.
J Thorac Oncol
; 17(11): 1276-1286, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35908731
11.
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy.
Cancers (Basel)
; 14(2)2022 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053597
12.
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 23(7): e489-e499, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35948460
13.
Timeline of SARS-CoV-2 Spread in Italy: Results from an Independent Serological Retesting.
Viruses
; 14(1)2021 12 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35062265
14.
Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy.
Tumori
; 107(5): 446-451, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33176598
15.
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments.
J Thorac Oncol
; 16(8): 1298-1311, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33887464
16.
Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis.
Cancers (Basel)
; 12(7)2020 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646072
17.
Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system.
Transl Lung Cancer Res
; 9(3): 617-628, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32676324
18.
Exo-miRNAs as a New Tool for Liquid Biopsy in Lung Cancer.
Cancers (Basel)
; 11(6)2019 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31242686
19.
Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Oncotarget
; 10(57): 6043, 2019 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31666934
20.
Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study.
Clin Cancer Res
; 25(7): 2166-2173, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30617131